Completed OBSERVATIONAL NCT00910078

Serum Free Light Change in Multiple Myeloma

Serum Free Light Chain Ratio, Total Kappa/Lambda Ratio, and Immunofixation as Prognostic Factors in Multiple Myeloma.

Sponsor: Azienda Ospedaliera San Giovanni Battista

Updated 6 times since 2017 Last updated: May 28, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Multiple Myeloma, this trial is completed. The trial is conducted by Azienda Ospedaliera San Giovanni Battista and has accumulated 6 data snapshots since 2026. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None

▶ Show 1 earlier version

Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Azienda Ospedaliera San Giovanni Battista

Data source: Azienda Ospedaliera San Giovanni Battista

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Torino, Italy